Alteration in gene expression profile by full-length hepatitis B virus genome

Intervirology

Volumn 48, Issue 2-3, 2005, Pages 77-83

  Nakanishi, Fumihiko ^a   Ohkawa, Kazuyoshi ^a   Ishida, Hisashi ^a   Hosui, Atsushi ^a   Sato, Aki ^a   Hiramatsu, Naoki ^a   Ueda, Keiji ^a   Takehara, Tetsuo ^a   Kasahara, Akinori ^a   Sasaki, Yutaka ^b   Hori, Masatsugu ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Corroboration assay; DNA array assay; Hepatitis B virus; Hepatitis B virus expressing cell; Hepatocarcinogenesis

Indexed keywords

CASPASE 3; HEAT SHOCK PROTEIN; HERMES ANTIGEN; PROTEIN BAX; SYNAPSIN I; THYMOSIN BETA10; VIRUS RNA; BAX PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASPASE; HIGH MOBILITY GROUP A1A PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN BCL 2; THYMOSIN; THYMOSIN BETA(10); VIRUS DNA;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; HEPATITIS B VIRUS; HOST CELL; HUMAN; HUMAN CELL; HUMAN GENOME; LIVER CARCINOGENESIS; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION; VIRUS EXPRESSION; VIRUS GENOME; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY; WESTERN BLOTTING;

HEPATITIS B VIRUS;

ANTIGENS, CD44; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CASPASES; CELL LINE, TUMOR; DNA, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, VIRAL; HEAT-SHOCK PROTEINS; HEPATITIS B VIRUS; HEPATOCYTES; HMGA1A PROTEIN; HUMANS; NUCLEOSIDE-DIPHOSPHATE KINASE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMOSIN;

EID: 23844450391     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081732     Document Type: Article

References (46)

1. Beasley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan. Lancet 1981;ii:1129-1133.
2. Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB: Survival in chronic hepatitis B: An analysis of 379 patients. Ann Intern Med 1984;101:613-616.
3. Hohne M, Schaefer S, Seifer M, Feitelson MA, Paul D, Gerlich WH: Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 1990;9:1137-1145.
4. Kim CM, Koike K, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991;351:317-320.
5. Wang XW, Gibson MK, Vermeulen W, Yeh H, Forrester K, Sturzbecher HW, Hoeijmakers JH, Harris CC: Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 1995;55:6012-6016.
6. Su F, Schneider RJ: Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 1997;94:8744-8749.
7. Gottlob K, Fulco M, Levrero M, Graessmann A: The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 1998;273:33347-33353.
8. Andrisani OM, Barnabas S: The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (review). Int J Oncol 1999;15:373-379.
9. Benn J, Schneider RJ: Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 1994;91:10350-10354.
10. Klein NP, Schneider RJ: Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol 1997;17:6427-6436.
11. Kekule AS, Lauer U, Weiss L, Luber B, Hofschneider PH: Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 1993;361:742-745.
12. Benn J, Su F, Doria M, Schneider RJ: Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 1996;70:4978-4985.
13. Chirillo P, Falco M, Puri PL, Artini M, Balsano C, Levrero M, Natoli G: Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway. J Virol 1996;70:641-646.
14. Maguire HF, Hoeffler JP, Siddiqui A: HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 1991;252:842-844.
15. Cheong JH, Yi M, Lin Y, Murakami S: Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 1995;14:143-150.
16. Lin Y, Nomura T, Cheong J, Dorjsuren D, Iida K, Murakami S: Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem 1997;272:7132-7139.
17. Qadri I, Conaway JW, Conaway RC, Schaack J, Siddiqui A: Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH. Proc Natl Acad Sci USA 1996;93:10578-10583.
18. Qadri I, Maguire HF, Siddiqui A: Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 1995;92:1003-1007.
19. Feitelson MA, Zhu M, Duan LX, London WT: Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 1993;8:1109-1117.
20. Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS, Transy C: Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol 1997;71:6194-6199.
21. Rahmani Z, Huh KW, Lasher R, Siddiqui A: Hepatitis B virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential. J Virol 2000;74:2840-2846.
22. Ono M, Morisawa K, Nie J, Ota K, Taniguchi T, Saibara T, Onishi S: Transactivation of transforming growth factor alpha gene by hepatitis B virus preS1. Cancer Res 1998;58:1813-1816.
23. Kekule AS, Lauer U, Meyer M, Caselmann WH, Hofschneider PH, Koshy R: The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature 1990;343:457-461.
24. Tsurimoto T, Fujiyama A, Matsubara K: Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl Acad Sci USA 1987;84:444-448.
25. Haramaki M, Yano H, Fukuda K, Momosaki S, Ogasawara S, Kojiro M: Expression of CD44 in human hepatocellular carcinoma cell lines. Hepatology 1995;21:1276-1284.
26. Mathew J, Hines JE, Obafunwa JO, Burr AW, Toole K, Burt AD: CD44 is expressed in hepatocellular carcinomas showing vascular invasion. J Pathol 1996;179:74-79.
27. Lara-Pezzi E, Serrador JM, Montoya MC, Zamora D, Yanez-Mo M, Carretero M, Furthmayr H, Sanchez-Madrid F, Lopez-Cabrera M: The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: Possible role of HBx in invasion and metastasis. Hepatology 2001;33:1270-1281.
28. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JB, Liotta LA, Sobel M: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-204.
29. Iizuka N, Oka M, Noma T, Nakazawa A, Hirose K, Suzuki T: NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma. Cancer Res 1995;55:652-657.
30. Boix L, Bruix J, Campo E, Sole M, Castells A, Fuster J, Rivera F, Cardesa A, Rodes J: nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology 1994;107:486-491.
31. Chiappetta G, Tallini G, De Biasio MC, Manfioletti G, Martinez-Tello FJ, Pentimalli F, de Nigris F, Mastro A, Botti G, Fedele M, Berger N, Santoro M, Giancotti V, Fusco A: Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res 1998;58:4193-4198.
32. Abe N, Watanabe T, Sugiyama M, Uchimura H, Chiappetta G, Fusco A, Atomi Y: Determination of high mobility group I(Y) expression level in colorectal neoplasias: A potential diagnostic marker. Cancer Res 1999;59:1169-1174.
33. Abe N, Watanabe T, Masaki T, Mori T, Sugiyama M, Uchimura H, Fujioka Y, Chiappetta G, Fusco A, Atomi Y: Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins. Cancer Res 2000;60:3117-3122.
34. Reeves R, Edberg DD, Li Y: Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol Cell Biol 2001;21:575-594.
35. Santelli G, Califano D, Chiappetta G, Vento MT, Bartoli PC, Zullo F, Trapasso F, Viglietto G, Fusco A: Thymosin β-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 1999;155:799-804.
36. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS: Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000;60:7099-7105.
37. Love S, King RJ: A 27 kDa heat shock protein that has anomalous prognostic powers in early and advanced breast cancer. Br J Cancer 1994;69:743-748.
38. Han J, Yoo HY, Choi BH, Rho HM: Selective transcriptional regulations in the human liver cell by hepatitis B viral X protein. Biochem Biophys Res Commun 2000;272:525-530.
39. Fabris C, Pirisi M, Soardo G, Toniutto P, Falleti E, Vitulli D, Pezzetta F, Gonano F, Bartoli E: Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma. Cancer Invest 1996;14:103-108.
40. 1-antitrypsin and survival in hepatocellular carcinoma. Br J Cancer 1990;61:72-73.
41. Beerheide W, Tan YJ, Teng E, Ting AE, Jedpiyawongse A, Srivatanakul P: Downregulation of proapoptotic proteins Bax and Bcl-Xs in p53 overexpressing hepatocellular carcinomas. Biochem Biophys Res Commun 2000;273:54-61.
42. Shimasaki S, Ling N: Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 1991;3:243-266.
43. Mirski SEL, Voskoglou-Nomikos T, Young LC, Deeley RG, Campling BG, Gerlach JH, Cole SPC: Simultaneous quantitation of topoisomerase II α and β isoform mRNAs in lung tumor cells and normal and malignant lung tissue. Lab Invest 2000;80:787-795.
44. Wang GL, Semenza GL: General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993;90:4304-4308.
45. Masiakowski P, Carroll RD: A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 1992;267:26181-26190.
46. Watanabe N, Kurabayashi M, Shimomura Y, Kawai-Kowase K, Hoshino Y, Manabe I, Watanabe M, Aikawa M, Kuro-o M, Suzuki T, Yazaki Y, Nagai R: BTEB2, a Kruppel-like transcription factor, regulates expression of the SMemb/nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ Res 1999;85:182-191.